GSA Capital Partners’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,940
| Closed | -$136K | – | 1561 |
|
|
2023
Q3 | $136K | Sell |
7,940
-7,024
| -47% | -$120K | 0.01% | 1358 |
|
|
2023
Q2 | $449K | Sell |
14,964
-3,138
| -17% | -$94.2K | 0.04% | 811 |
|
|
2023
Q1 | $529K | Sell |
18,102
-1,849
| -9% | -$54K | 0.05% | 674 |
|
|
2022
Q4 | $394K | Buy |
19,951
+14,295
| +253% | +$282K | 0.05% | 751 |
|
|
2022
Q3 | $171K | Buy |
+5,656
| New | +$171K | 0.02% | 1275 |
|
|
2021
Q3 | – | Sell |
-1,786
| Closed | -$155K | – | 1498 |
|
|
2021
Q2 | $155K | Sell |
1,786
-513
| -22% | -$44.5K | 0.02% | 1216 |
|
|
2021
Q1 | $102K | Buy |
2,299
+946
| +70% | +$42K | 0.02% | 1000 |
|
|
2020
Q4 | $35K | Buy |
+1,353
| New | +$35K | 0.01% | 1144 |
|